Sermonix Pharmaceuticals to Host Oral Presentation on Vaginal and Sexual Health at RISE UP for Breast Cancer Conference
21 oct. 2024 09h00 HE
|
Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast...
CLS Americas Announces 2nd Order of TRANBERG™ Focal Laser Ablation Accessories Placed by the National Institutes of Health Clinical Center
09 avr. 2024 02h30 HE
|
Clinical Laserthermia Systems Americas, Inc.
CLS Americas received its second order from the National Institutes of Health Clinical Center (NIHCC) for its TRANBERG Thermal Therapy System accessories.
Sermonix Pharmaceuticals Shares Results of Third Survey on ESR1 and Metastatic Breast Cancer Patient Quality of Life
12 déc. 2023 09h00 HE
|
Sermonix Pharmaceuticals Inc.
Most patients minimized or hid side effects from their health care providers for fear of negative perceptions, reduced treatment efficacy, or being taken off a drug or out of a clinical trialSexual...
Clearday Redefines the Landscape of Care Through Groundbreaking Technologies
11 déc. 2023 08h00 HE
|
Clearday, Inc.
San Antonio, Texas, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Clearday, Inc. (CLRD-OTCQX) is committed to redefining the landscape of Care for Older Adults through groundbreaking technologies and...
Loadsmart’s Opendock Reduces Shipment Delays at the Warehouse, Improves Carrier Safety
11 mai 2022 10h00 HE
|
Loadsmart
CHICAGO, May 11, 2022 (GLOBE NEWSWIRE) -- Loadsmart, a leading freight technology company, announced today that 70,000 carriers have scheduled seven million appointments at 3,000 warehouses within...
USA Equities Corp. Launches Q-Scale Product to Meet Growing Mental Health End Market Demand
19 oct. 2021 08h30 HE
|
USA Equities Corp
Strengthening Business Model and Expanding Product Portfolio in Large Addressable End MarketQ-Scale Represents a Compelling and Reimbursable Value Proposition for USAQ’s Physician ClientsFurther...
Processa Pharmaceuticals Schedules Conference Call to Discuss Second Quarter Results and Provide Drug Development Update on August 12 at 5:30 p.m. EST
06 août 2021 08h30 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, Md., Aug. 06, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical stage biopharmaceutical company developing products to improve the survival and/or quality...
Processa Pharmaceuticals to Present at “Zooming with LD Micro” Virtual Investor Event on July 29, 2021 at 12:00 p.m. ET
27 juil. 2021 08h30 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, July 27, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) announced today that it will be presenting at the upcoming “Zooming with LD Micro” virtual investor event...
Policy thought-leaders, Don Drummond and Duncan Sinclair, release long-term care report seeking to reshape the future for Canadian seniors
27 nov. 2020 07h00 HE
|
Ageing Well
KINGSTON, Ontario, Nov. 27, 2020 (GLOBE NEWSWIRE) -- Today, renowned public policy experts Don Drummond and Duncan Sinclair released a long-term care (LTC) research report that calls for...
Oregon Coalition for Living Well with Serious Illness Launches with Commitment to a Person-Centered Ecosystem of Care
08 avr. 2019 10h01 HE
|
Cambia Health Foundation
PORTLAND, Ore., April 08, 2019 (GLOBE NEWSWIRE) -- On April 8, 2019, the Oregon Coalition for Living Well with Serious Illness formally launches and affirms its commitment to building a...